Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (NDUFS5) is a small accessory subunit of mitochondrial complex I, the first enzyme complex of the respiratory electron transport chain located in the inner mitochondrial membrane[1][8]. NDUFS5 is not directly involved in catalysis but is required for the correct assembly and stability of complex I. Complex I catalyzes the transfer of electrons from NADH to ubiquinone, coupling this process to proton translocation and ATP synthesis in oxidative phosphorylation[1][2][8]. Mutations or deficiencies in NDUFS5 are associated with mitochondrial complex I deficiency, manifesting as diverse mitochondrial disorders including progressive leukoencephalopathy and ovarian failure[1][7].
Inhibitors of complex I block electron transfer from NADH to ubiquinone, leading to impaired mitochondrial respiration and ATP synthesis, but these do not specifically select the NDUFS5 subunit[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (NDUFS5).